Paysign, Inc. (NASDAQ:PAYS) Insider Topline Capital Management, Ll Sells 120,000 Shares

Paysign, Inc. (NASDAQ:PAYS) insider Topline Capital Management, Ll sold 120,000 shares of the stock in a transaction on Tuesday, January 14th. The stock was sold at an average price of $3.24, for a total value of $388,800.00. Following the completion of the transaction, the insider now directly owns 5,336,146 shares in the company, valued at $17,289,113.04. This trade represents a 2.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Topline Capital Management, Ll also recently made the following trade(s):

• On Monday, December 30th, Topline Capital Management, Ll sold 227,084 shares of Paysign stock. The stock was sold at an average price of $3.07, for a total value of $697,147.88.
• On Friday, December 27th, Topline Capital Management, Ll sold 231,187 shares of Paysign stock. The shares were sold at an average price of $3.31, for a total value of $765,228.97.

Paysign Price Performance

Shares of PAYS stock opened at $3.04 on Friday. The company’s fifty day moving average price is $3.21 and its two-hundred day moving average price is $3.93. The firm has a market capitalization of $162.79 million, a P/E ratio of 20.27 and a beta of 0.95. Paysign, Inc. has a 12 month low of $2.48 and a 12 month high of $5.59.

Paysign (NASDAQ:PAYS) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of $0.01 by $0.02. The business had revenue of $15.26 million for the quarter, compared to analysts’ expectations of $14.96 million. Paysign had a net margin of 14.28% and a return on equity of 30.64%. During the same quarter last year, the company posted $0.02 earnings per share. On average, sell-side analysts anticipate that Paysign, Inc. will post 0.21 EPS for the current year.

Analysts Set New Price Targets

Several research firms have recently issued reports on PAYS. Barrington Research reissued an “outperform” rating and issued a $7.00 price objective on shares of Paysign in a research report on Monday, November 4th. Lake Street Capital initiated coverage on Paysign in a research report on Friday, December 20th. They issued a “buy” rating and a $6.00 target price for the company.

Institutional Investors Weigh In On Paysign

A number of institutional investors have recently made changes to their positions in the company. SG Americas Securities LLC lifted its position in shares of Paysign by 33.5% in the 4th quarter. SG Americas Securities LLC now owns 15,508 shares of the company’s stock worth $47,000 after buying an additional 3,895 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Paysign by 5.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 85,964 shares of the company’s stock valued at $371,000 after purchasing an additional 4,248 shares during the period. Sanctuary Advisors LLC grew its stake in Paysign by 4.3% during the 3rd quarter. Sanctuary Advisors LLC now owns 121,089 shares of the company’s stock worth $419,000 after buying an additional 5,000 shares during the last quarter. Rhumbline Advisers increased its position in Paysign by 25.1% in the second quarter. Rhumbline Advisers now owns 35,835 shares of the company’s stock worth $154,000 after buying an additional 7,190 shares during the period. Finally, Algert Global LLC acquired a new stake in Paysign in the second quarter worth $46,000. 25.89% of the stock is currently owned by institutional investors.

About Paysign

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.